ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
63,864.93
0.72%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. AbbVie Inc (ABBV)

  7. AbbVie Inc (ABBV) 뉴스

ABBV AbbVie Inc

159.6218
-7.67 (-4.58%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
AbbVie Inc ABBV NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
-7.67 -4.58% 159.6218 09:00:00
개장가 저가 고가 종가 전일 종가
167.26 157.65 167.46 159.62 167.29
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/04/202420:47IHMARKETNEWSU.S. Futures Climb in Pre-Market Trading Amid Tech Gains and..
26/04/202420:35PRNUSAbbVie Reports First-Quarter 2024 Financial Results
25/04/202421:00PRNUSNew Data Show RINVOQ® (upadacitinib) Demonstrated..
23/04/202421:00PRNUSAllergan Aesthetics Invites Consumers to Be the Face of..
18/04/202421:31PRNUSPhase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed..
12/04/202420:30PRNUSAbbVie Announces Late-Breaking Data at AAN Supporting..
09/04/202421:00PRNUSSkinMedica® Empowers Clear Skin Confidence with a New,..
04/04/202421:00PRNUSAbbVie to Host First-Quarter 2024 Earnings Conference Call
03/04/202421:30PRNUSAllergan Aesthetics Announces the Return of CoolMonth with..
01/04/202420:50GLOBENEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an..
26/03/202420:20IHMARKETNEWSSuper Micro Computer and Seagate Shares Surge on Analyst..
26/03/202400:00PRNUSAllergan Aesthetics Launches "Moving the Needle on Ethics"..
25/03/202421:31PRNUSAbbVie to Acquire Landos Biopharma, Further Strengthening..
25/03/202421:30GLOBEAbbVie to Acquire Landos Biopharma, Further Strengthening..
23/03/202404:02PRNUSU.S. Food and Drug Administration (FDA) Grants Full Approval..
21/03/202421:00PRNUSALLERGAN AESTHETICS CONTINUES TO CHAMPION INDIVIDUALITY,..
07/03/202422:00PRNUSAbbVie to Present at the Barclays 26th Annual Global..
06/03/202422:03PRNUSAbbVie and Allergan Aesthetics to Present New Data at 2024..
06/03/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202402:09PRNCADragonfly a reçu un paiement d'étape à la suite de la prise..
05/03/202422:00PRNUSJUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA..
05/03/202421:00PRNCADragonfly has Received Milestone Payment Following Dosing of..
02/03/202409:53EDGAR2Form 144 - Report of proposed sale of securities
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/03/202406:20EDGAR2Form 144 - Report of proposed sale of securities
01/03/202408:06EDGAR2Form 144 - Report of proposed sale of securities
01/03/202407:33EDGAR2Form 144 - Report of proposed sale of securities
01/03/202406:04EDGAR2Form 144 - Report of proposed sale of securities
28/02/202414:05PRNUSAbbVie and OSE Immunotherapeutics Announce Partnership to..
28/02/202407:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202422:00PRNUSAbbVie to Present at the TD Cowen 44th Annual Health Care..
27/02/202421:45PRNUSU.S. Food and Drug Administration (FDA) Grants Priority..
27/02/202407:08EDGAR2Form 8-K - Current report
26/02/202420:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/02/202407:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202406:04EDGAR2Form 144 - Report of proposed sale of securities
22/02/202422:05PRNUSAbbVie and Tentarix Announce Collaboration to Develop..
22/02/202408:00EDGAR2Form 144 - Report of proposed sale of securities
21/02/202422:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/02/202422:00PRNUSBOTOX® Cosmetic (onabotulinumtoxinA) Announces Its 2024..
21/02/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

NYSE
ABBV
AbbVie
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유